Vicente Vicente Selected Research

myeloma immunoglobulins

10/2016

Identification of a new potential mechanism responsible for severe bleeding in myeloma: immunoglobulins bind the heparin binding domain of antithrombin activating this endogenous anticoagulant.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vicente Vicente Research Topics

Disease

34	Thrombosis (Thrombus) 06/2022 - 08/2002
30	Atrial Fibrillation 10/2021 - 09/2004
29	Hemorrhage 01/2022 - 01/2003
21	Neoplasms (Cancer) 06/2022 - 10/2004
18	Venous Thrombosis (Deep-Vein Thrombosis) 11/2021 - 08/2002
15	Stroke (Strokes) 11/2020 - 09/2006
14	Myocardial Infarction 11/2020 - 08/2002
12	Thrombophilia 01/2022 - 05/2008
12	Inflammation (Inflammations) 02/2021 - 09/2004
10	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2022 - 05/2014
7	Ischemic Stroke 12/2019 - 09/2006
6	Cardiovascular Diseases (Cardiovascular Disease) 11/2020 - 07/2003
6	Breast Neoplasms (Breast Cancer) 10/2019 - 07/2003
5	Acute Coronary Syndrome 01/2018 - 12/2007
4	Neoplasm Metastasis (Metastasis) 06/2022 - 07/2005
4	Venous Thromboembolism 02/2021 - 05/2008
4	Atherosclerosis 01/2021 - 09/2004
4	Vascular Diseases (Vascular Disease) 01/2021 - 03/2014
4	Lymphoma (Lymphomas) 01/2020 - 06/2012
4	Heart Failure 01/2018 - 03/2014
4	Thrombasthenia (Glanzmann Thrombasthenia) 11/2017 - 04/2002
3	Thrombocytopenia (Thrombopenia) 01/2021 - 11/2017
3	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 01/2020 - 10/2013
3	Infections 01/2020 - 12/2004
3	Thromboembolism 12/2019 - 06/2011
3	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2018 - 03/2016
3	Hypertension (High Blood Pressure) 11/2015 - 08/2010
3	Essential Thrombocythemia 12/2014 - 06/2009
3	Obesity 05/2014 - 01/2008
3	Wounds and Injuries (Trauma) 02/2014 - 09/2004
3	Necrosis 01/2013 - 02/2008
3	Melanoma (Melanoma, Malignant) 06/2009 - 01/2004
2	Inborn Genetic Diseases (Disease, Hereditary) 08/2022 - 01/2018
2	Colorectal Neoplasms (Colorectal Cancer) 06/2022 - 01/2020
2	Disease Susceptibility (Diathesis) 01/2021 - 01/2019
2	COVID-19 01/2021 - 01/2021
2	Congenital Disorders of Glycosylation 10/2020 - 11/2019
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2020 - 02/2019
2	Disseminated Intravascular Coagulation 01/2020 - 01/2016
2	Pulmonary Embolism 12/2019 - 06/2010
2	Residual Neoplasm 10/2019 - 11/2014
2	Multiple Myeloma 02/2019 - 03/2008
2	Hemolysis 01/2019 - 03/2016
2	Transient Ischemic Attack 07/2017 - 09/2014
2	Bernard-Soulier Syndrome (Giant Platelet Syndrome) 01/2017 - 11/2016

Drug/Important Bio-Agent (IBA)

34	AntithrombinsIBA 01/2022 - 11/2003
19	Proteins (Proteins, Gene)FDA Link 02/2021 - 08/2006
18	AnticoagulantsIBA 10/2021 - 04/2007
12	Biomarkers (Surrogate Marker)IBA 06/2022 - 06/2011
12	Vitamin K FDA Link 11/2020 - 04/2012
10	Hemostatics (Antihemorrhagics)IBA 01/2022 - 03/2005
9	Inosine Triphosphate (ITP)IBA 01/2022 - 05/2014
9	MicroRNAs (MicroRNA)IBA 01/2021 - 03/2011
8	SerpinsIBA 01/2016 - 09/2004
7	Biological ProductsIBA 10/2020 - 07/2003
6	Factor XIII (Coagulation Factor XIII)IBA 09/2010 - 08/2002
5	von Willebrand FactorIBA 01/2021 - 06/2011
5	AcenocoumarolIBA 03/2018 - 11/2015
4	Thrombin FDA Link 01/2021 - 03/2009
4	Factor XII (Hageman Factor)IBA 10/2020 - 12/2005
4	FibrinIBA 01/2018 - 04/2005
4	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2018 - 07/2008
4	Warfarin (Coumadin)FDA LinkGeneric 01/2018 - 04/2012
4	Prothrombin (Factor II)IBA 01/2017 - 08/2002
4	factor V LeidenIBA 11/2010 - 05/2008
3	Thrombopoietin ReceptorsIBA 08/2021 - 11/2019
3	DNA (Deoxyribonucleic Acid)IBA 02/2021 - 02/2014
3	Dacarbazine (DIC)FDA LinkGeneric 01/2021 - 01/2016
3	Fibrinogen (Factor I)FDA Link 01/2021 - 09/2004
3	Heparin (Liquaemin)FDA LinkGeneric 01/2021 - 01/2016
3	AntigensIBA 10/2020 - 12/2004
3	Adenosine Diphosphate (ADP)IBA 01/2020 - 05/2009
3	Protein CIBA 12/2019 - 04/2007
3	eculizumab FDA Link 11/2019 - 03/2016
3	Interleukin-6 (Interleukin 6)IBA 01/2018 - 10/2004
3	Dabigatran FDA Link 01/2018 - 06/2015
3	EnzymesIBA 11/2017 - 12/2004
3	IntegrinsIBA 01/2016 - 07/2003
3	AnthracyclinesIBA 06/2015 - 02/2012
3	LipidsIBA 08/2010 - 08/2006
3	Integrin beta3 (GPIIIa)IBA 07/2010 - 04/2002
3	plasma protein Z (protein Z)IBA 04/2007 - 05/2005
3	Protease Inhibitors (Protease Inhibitor)IBA 04/2007 - 05/2005
2	Factor XI (Plasma Thromboplastin Antecedent)IBA 10/2021 - 11/2019
2	LipopolysaccharidesIBA 01/2021 - 04/2005
2	fibrin fragment D (D-dimer)IBA 01/2021 - 06/2011
2	Congenital disorder of glycosylation type 1AIBA 10/2020 - 10/2013
2	Polysaccharides (Glycans)IBA 01/2020 - 01/2017
2	CollagenIBA 01/2020 - 07/2008
2	Pharmaceutical PreparationsIBA 11/2019 - 07/2006
2	Estrogen ReceptorsIBA 10/2019 - 01/2018
2	Vitamin K Epoxide ReductasesIBA 06/2018 - 01/2013
2	apixabanIBA 01/2018 - 06/2015

Therapy/Procedure

29	Therapeutics 01/2022 - 02/2008
6	Drug Therapy (Chemotherapy) 06/2015 - 07/2005
5	Neoadjuvant Therapy 05/2022 - 11/2014
4	Thrombolytic Therapy 09/2010 - 08/2002
3	Platelet Transfusion (Blood Platelet Transfusions) 10/2018 - 01/2016
2	Aftercare (After-Treatment) 05/2022 - 03/2007
2	Splenectomy 01/2022 - 11/2019